Wed, Jan 28, 2015, 7:02 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

OncoSec Medical Incorporated Message Board

  • jim.beemer Sep 16, 2013 9:42 AM Flag

    ONCS Will Have Cash For 2 Years and Eliminates Future Risk of Financing.

    ONCS is one of the most responsible biotechs that I cover. They burn less than $600k per month, or less than $7 million a year! Most biotechs with two clinical programs spend $7m in a quarter, or more.

    SRPT spent $19 million last quarter, and their ph.2 program is complete, and only enrolled 12 patients. ONCS is very responsible with their money, and if they raise $12m, I'd say it eliminates the fear of financing for two years, then ONCS can rally on its future news (data).

    While it hurts today, this is great news long-term. All biotechs dilute shares. It's part of the industry.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
0.385-0.009(-2.41%)Jan 28 3:59 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Facebook, Inc.
NASDAQWed, Jan 28, 2015 4:00 PM EST
Core Laboratories NV
NYSEWed, Jan 28, 2015 4:01 PM EST
Qwest Corp.
NYSEWed, Jan 28, 2015 4:00 PM EST